Replies to post #72004 on Muscle Pharm Corporation (MSLPQ)

[TheExpertHimself]

Musclepharm doesn't lose that much money though.
Under the current level of compensation and endorsement expenses, I admit that it will be hard for Musclepharm to turn a profit in Q4.

However, in 2015, this picture may turn....The expenses that aren't fixed will have to come down. Also, the dilution will have to come down to the nominal levels of other public companies and the sales have to grow at double digits.

If Musclepharm manages to show us such restraint on the input side while boosting the output...then better times are ahead of us....